Literature DB >> 31764108

High yield of new HIV diagnoses during active case-finding for tuberculosis.

Walter Mchembere1, Janet Agaya, Courtney M Yuen, Douglas Okelloh, Millicent Achola, Joseph Opole, Jessica Cowden, Hellen Muttai, Charles M Heilig, Martien W Borgdorff, Kevin P Cain.   

Abstract

OBJECTIVE: To evaluate the utility of a broad and nonspecific symptom screen for identifying people with undiagnosed HIV infection.
DESIGN: Secondary analysis of operational data collected during implementation of a cluster-randomized trial for tuberculosis case detection.
METHODS: As part of the trial, adults reporting cough, fever, night sweats, weight loss, or difficulty breathing for any duration in the past month were identified in health facilities and community-based mobile screening units in western Kenya. Adults reporting any symptom were offered HIV testing. We analysed the HIV testing data from this study, using modified Poisson regression, to identify predictors of new HIV diagnoses among adults with symptoms and initially unknown HIV status.
RESULTS: We identified 3818 symptomatic adults, referred 1424 (37%) for testing, of whom 1065 (75%) accepted, and 107 (10%) were newly diagnosed with HIV. The prevalence of new HIV diagnoses was 21% [95% confidence interval (CI) 17-25%] among those tested in health facilities and 5% (95% CI 4-7%) among those tested in mobile units. More men were diagnosed with HIV than women, despite fewer men being screened. People who reported 4-5 symptoms were over twice as likely to be diagnosed with HIV compared to those reporting 1-3 symptoms (adjusted prevalence ratio in health facilities = 2.58, 95% CI 1.65-4.05; adjusted prevalence ratio in mobile units = 2.63, 95% CI 1.37-5.03).
CONCLUSION: We observed a high yield of new HIV diagnoses among adults identified by active application of a broad symptom screen. Use of integrated tuberculosis and HIV screening could help close the detection gap for both conditions.

Entities:  

Mesh:

Year:  2019        PMID: 31764108      PMCID: PMC9554931          DOI: 10.1097/QAD.0000000000002354

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  12 in total

1.  Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention.

Authors:  P Srikantiah; R Lin; M Walusimbi; A Okwera; H Luzze; C C Whalen; W H Boom; D V Havlir; E D Charlebois
Journal:  Int J Tuberc Lung Dis       Date:  2007-02       Impact factor: 2.373

2.  Optimizing the efficiency of tuberculosis active case-finding in health facilities and communities.

Authors:  C M Yuen; J Agaya; W Mchembere; D Okelloh; M Achola; J Opole; J Cowden; C M Heilig; M W Borgdorff; K P Cain
Journal:  Int J Tuberc Lung Dis       Date:  2019-07-01       Impact factor: 2.373

Review 3.  Kenya AIDS Indicator Surveys 2007 and 2012: implications for public health policies for HIV prevention and treatment.

Authors:  William K Maina; Andrea A Kim; George W Rutherford; Malayah Harper; Boniface O K'Oyugi; Shahnaaz Sharif; George Kichamu; Nicholas M Muraguri; Willis Akhwale; Kevin M De Cock
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

4.  Where are the positives? HIV testing in sub-Saharan Africa in the era of test and treat.

Authors:  Kevin M De Cock; Joseph L Barker; Rachel Baggaley; Wafaa M El Sadr
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

5.  Investigation outcomes of tuberculosis suspects in the health centers of Addis Ababa, Ethiopia.

Authors:  Amare Deribew; Nebiyu Negussu; Zenebe Melaku; Kebede Deribe
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

6.  Provider-Initiated HIV testing and counseling among patients with presumptive tuberculosis in Democratic Republic of Congo.

Authors:  Marcel Yotebieng; Landry Kipula Wenzi; Emmanuel Basaki; Marie Louise Batumbula; Martine Tabala; Eugenie Mungoyo; Richard Mangala; Frieda Behets
Journal:  Pan Afr Med J       Date:  2016-11-15

7.  Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya.

Authors:  Masini Enos; Joseph Sitienei; Jane Ong'ang'o; Brenda Mungai; Maureen Kamene; Jesse Wambugu; Hillary Kipruto; Veronica Manduku; Josephine Mburu; Drusilla Nyaboke; Faith Ngari; Eunice Omesa; Newton Omale; Nkirote Mwirigi; Geoffrey Okallo; Janice Njoroge; Martin Githiomi; Mike Mwangi; Dickson Kirathe; Richard Kiplimo; Amos Ndombi; Lazarus Odeny; Eunice Mailu; Timothy Kandie; Maurice Maina; Kadondi Kasera; Beatrice Mulama; Beatrice Mugi; Herman Weyenga
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

8.  Feasibility and effectiveness of provider initiated HIV testing and counseling of TB suspects in Vizianagaram district, South India.

Authors:  Shanta Achanta; Ajay M V Kumar; Sharath Burugina Nagaraja; Jyoti Jaju; Srinivas Rao Motta Shamrao; Ramakrishna Uppaluri; Rama Rao Tekumalla; Devesh Gupta; Ashok Kumar; Srinath Satyanarayana; Puneet K Dewan
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

9.  Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study).

Authors:  Ann K Sullivan; Dorthe Raben; Joanne Reekie; Michael Rayment; Amanda Mocroft; Stefan Esser; Agathe Leon; Josip Begovac; Kees Brinkman; Robert Zangerle; Anna Grzeszczuk; Anna Vassilenko; Vesna Hadziosmanovic; Maksym Krasnov; Anders Sönnerborg; Nathan Clumeck; José Gatell; Brian Gazzard; Antonella d'Arminio Monforte; Jürgen Rockstroh; Jens D Lundgren
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

10.  Sex Differences in HIV Prevalence Persist over Time: Evidence from 18 Countries in Sub-Saharan Africa.

Authors:  Hanne K Hegdahl; Knut M Fylkesnes; Ingvild F Sandøy
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.